Objective: Topical application of ear drops containing ototoxic antibi
otics is commonly used for treatment of middle ear diseases. Because o
f their ototoxic potential, we evaluated the safety of these ear drops
in clinical use. Methods: The study included 446 children who underwe
nt myringotomy and the insertion of tympanostomy tubes. Three hundred
and fifty-eight received preventive treatment after the operation with
polymyxin B-neomycin-dexamethasone ear drops for 2 weeks; 88 did not
receive any ear drops. Audiometric tests were performed before the ope
ration and up to 3 months following it. Results: All 446 children had
a normal sensorineural hearing threshold before and after the operatio
n. There was no sensorineural hearing loss in the group that was treat
ed with ear drops. Conclusions: Our experience leads us to believe tha
t topical ear drops containing ototoxic antibiotics are clinically saf
e to use for a short period of time.